1. Lee H, Jung HK, Huh KC. Functional Dyspepsia Study Group in the Korean Society of Neurogastroenterology and Motility. 2014; Current status of functional dyspepsia in Korea. Korean J Intern Med. 29:156–165. DOI:
10.3904/kjim.2014.29.2.156. PMID:
24648796. PMCID:
PMC3956983.
Article
4. Min BH, Huh KC, Jung HK, et al. 2014; Prevalence of uninvestigated dyspepsia and gastroesophageal reflux disease in Korea: a population-based study using the Rome III criteria. Dig Dis Sci. 59:2721–2729. DOI:
10.1007/s10620-014-3243-y. PMID:
24925147.
Article
7. Oh JH, Kwon JG, Jung HK, et al. 2020; Clinical practice guidelines for functional dyspepsia in Korea. J Neurogastroenterol Motil. 26:29–50. DOI:
10.5056/jnm19209. PMID:
31917913. PMCID:
PMC6955183.
Article
9. Lee JW, Youn YH, Choi SC, Lee KJ, Kim N. 2021; Multicenter, randomized, placebo-controlled trial to evaluate the efficacy and safety of a controlled-release, once-daily UIC201609/UIC201610 combination therapy for functional dyspepsia: preliminary study. Korean J Gastroenterol. 77:171–178. DOI:
10.4166/kjg.2020.171. PMID:
33854007.
Article
10. Yoon H, Lee DH, Lee YH, et al. 2018; Efficacy and safety of UI05MSP015CT in functional dyspepsia: a randomized, controlled trial. Gut Liver. 12:516–522. DOI:
10.5009/gnl17416. PMID:
29938452. PMCID:
PMC6143453.
Article
13. Pike BL, Porter CK, Sorrell TJ, Riddle MS. 2013; Acute gastroenteritis and the risk of functional dyspepsia: a systematic review and meta-analysis. Am J Gastroenterol. 108:1558–1564. DOI:
10.1038/ajg.2013.147. PMID:
23711623.
Article
14. Gwee KA. 2010; Post-infectious irritable bowel syndrome, an inflammation-immunological model with relevance for other IBS and functional dyspepsia. J Neurogastroenterol Motil. 16:30–34. DOI:
10.5056/jnm.2010.16.1.30. PMID:
20535323. PMCID:
PMC2879823.
Article